All Stories

  1. MANAGEMENT OF ENDOCRINE DISEASE: Rituximab therapy for Graves’ orbitopathy – lessons from randomized control trials
  2. THERAPY OF ENDOCRINE DISEASE: Endocrine dilemma: management of Graves’ orbitopathy
  3. Medical Treatment of Graves’ Orbitopathy
  4. Role of the anti-CD20 antibody Rituximab in Graves’ disease
  5. Statins May Increase the Risk of Liver Dysfunction in Patients Treated With Steroids for Active Graves' Orbitopathy
  6. Efficacy of B-Cell Targeted Therapy With Rituximab in Patients With Active Moderate to Severe Graves' Orbitopathy: A Randomized Controlled Study
  7. Potential Utility of Rituximab for Graves' Orbitopathy
  8. Small Dose of Rituximab for Graves Orbitopathy: New Insights Into the Mechanism of Action
  9. B Cell Depletion with Rituximab in Graves Disease and Associated Orbitopathy
  10. Rituximab treatment in patients with active Graves' orbitopathy: effects on proinflammatory and humoral immune reactions
  11. Management of Mild Graves’ Orbitopathy